Precipio Emerges as Top Buy in New Top 100 Stock List

Barchart added 10 new stocks to its Top 100 list, with Arena Group Holdings (AREN) and Precipio (PRPO) making notable appearances. Arena Group owns popular media brands while Precipio aids in more accurate patient diagnoses. Both stocks have shown strong momentum, but Precipio may be the better long-term investment due to its industry stability and revenue growth.

Arena Group has shown positive results recently, including profitability and revenue growth. However, the company still faces challenges, such as high debt levels and interest payments. On the other hand, Precipio operates in a growing industry and has shown potential for future revenue growth and improved results.

While both stocks have their risks and rewards, Precipio may be the more promising option for aggressive investors looking for potential long-term growth. Precipio, a medical laboratory company, shows potential for growth despite financial challenges. Share volume has surged, with third-party-payer revenue up 36% and products revenue expected to grow. The company’s gross margin is strong at 51%, making profitability achievable. While risky, investing in Precipio could pay off if the company reaches a tipping point. The company’s success hinges on avoiding issues with Medicaid and Medicare. This information is for informational purposes only, and the author does not hold positions in the mentioned securities.

Read more at 1. “Stock market reaches new record high as tech sector surges.” – CNBC
2. “Unemployment rate drops to 4% as economy continues to recover.” – Wall Street Journal
3. “FDA approves new cancer treatment with 90% success rate in clinical trials.” – Reuters
4. “Tesla announces plans to build new gigafactory in Texas.” – CBS MarketWatch
5. “Global oil prices rise 5% following OPEC production cuts.” – Barchart: 2 New Top 100 Stocks to Buy. Precipio’s the Buy.